التفاصيل البيبلوغرافية
| العنوان: |
Virtual clinical trial simulations for a novel KRASG12C inhibitor (ASP2453) in non‐small cell lung cancer. |
| المؤلفون: |
Sayama, Hiroyuki, Marcantonio, Diana, Nagashima, Takeyuki, Shimazaki, Masashi, Minematsu, Tsuyoshi, Apgar, Joshua F, Burke, John M., Wille, Lucia, Nagasaka, Yasuhisa, Kirouac, Daniel C. |
| المصدر: |
CPT: Pharmacometrics & Systems Pharmacology; Aug2021, Vol. 10 Issue 8, p864-877, 14p |
| مصطلحات موضوعية: |
NON-small-cell lung carcinoma, CLINICAL trials, CELL nuclei, TUMOR growth, PROGRESSION-free survival |
| مستخلص: |
KRAS is a small GTPase family protein that relays extracellular growth signals to cell nucleus. KRASG12C mutations lead to constitutive proliferation signaling and are prevalent across human cancers. ASP2453 is a novel, highly potent, and selective inhibitor of KRASG12C. Although preclinical data suggested impressive efficacy, it remains unclear whether ASP2453 will show more favorable clinical response compared to more advanced competitors, such as AMG 510. Here, we developed a quantitative systems pharmacology (QSP) model linking KRAS signaling to tumor growth in patients with non‐small cell lung cancer. The model was parameterized using in vitro ERK1/2 phosphorylation and in vivo xenograft data for ASP2453. Publicly disclosed clinical data for AMG 510 were used to generate a virtual population, and tumor size changes in response to ASP2453 and AMG 510 were simulated. The QSP model predicted ASP2453 exhibits greater clinical response than AMG 510, supporting potential differentiation and critical thinking for clinical trials. [ABSTRACT FROM AUTHOR] |
|
Copyright of CPT: Pharmacometrics & Systems Pharmacology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder